Require PSA blood tests to be proactively offered to men at highest risk of prostate cancer. Review emerging evidence from the TRANSFORM trial to inform a future national screening programme for prostate cancer. We believe this will make the health system fairer and reduce inequality.

Black men, men with a family history of prostate cancer, and men from socio-economically deprived areas are disproportionately impacted by prostate cancer. We believe that detecting and diagnosing prostate cancer is now safer and more accurate than ever. Prostate Cancer UK’s research suggests that harms of diagnosing prostate cancer have reduced by 79%. Yet it remains the second biggest cancer killer in men in the UK. We think it is time to review NHS guidelines on the PSA blood test and invest in an early detection programme.